Status: Recruiting
Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders
The goal of this clinical trial is to evalute the efficacy of ALZGUARD, a smartphone-based digital therapeutic(DTx), in comparison to diagnosis by medical doctors, as weel as to assess the safety of the application.
Participants needed: 122
Trial details
Age: 55-85Biological sex: AllType: InterventionalSponsor: HAII corp.ltdUpdated: Sep 26, 2024Locations: 3
Eligibility criteria
Participants must be between 55 and 85 years old (both men and women). [+1]
Participants with no literacy or illiteracy. [+6]